Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: Eight million in England To Face Toughest Virus Restrictions

Mon, 26th Oct 2020 18:57

(Alliance News) - More than eight million people in England will be under the most stringent coronavirus restrictions when Nottingham and Warrington move into Tier 3 this week.

Tougher measures will come into force in the Midlands city and the boroughs of Broxtowe, Gedling and Rushcliffe on Thursday, with details expected to be set out on Tuesday.

It came just hours after it was confirmed that Warrington will enter Tier 3 on Tuesday, with pubs and bars in the Cheshire town having to close unless they serve substantial meals.

Households will be banned from mixing indoors or in private gardens and beer gardens, while betting shops, adult gaming centres, casinos and soft play centres will also close.

Warrington Borough Council will receive a financial support package of GBP1.7 million to help contact tracing and enforcement, as well as GBP4.2 million in business support from the UK government.

The two areas will join the Liverpool City Region, Greater Manchester, Lancashire and South Yorkshire in Tier 3, placing 8.2 million people in England under the toughest restrictions.

The rate of coronavirus cases in Nottingham fell from 726.6 in the seven days to October 15 to 464.4 in the week to October 22, with 1,546 new cases, according to analysis by the PA news agency.

But in Warrington cases rose from 343.3 to 395.2 per 100,000 people over the same period, with 830 new cases.

In a joint statement, Nottingham City Council and Nottinghamshire County Council said the measures had been agreed to "achieve a sustained reduction in infection rates, especially to help protect our vulnerable residents, the NHS and social care services".

"A package of support similar to those secured in other parts of the country has been agreed to help residents and businesses who will be impacted by the new restrictions."

Earlier, Health Secretary Matt Hancock said it was "time to take action" in Warrington with rising infection rates.

"I know that these new measures will mean sacrifices must be made by the people in Warrington, and I want to extend my thanks to each and every one of them for recognising the severity of the situation and sticking to the rules.

"We have agreed a support package designed to help businesses while boosting efforts to control the virus locally, and will not hesitate to take similar action in any area of the country if infection rates continue to rise.

"Please remember – now is the time for us all to work together to get this virus under control."

And he told the BBC that areas under Tier 3 restrictions would have to prove that their infection rate was "coming down", especially among those aged 60 or over, before they could be removed from the strictest measures.

Mr Hancock has also refused to rule out bringing in a tougher set of Tier 4 impositions following reports another level is being considered to tackle England's rise in infections.

In other developments, Boris Johnson insisted the government would not allow children to go hungry amid mounting anger over his refusal to extend free school meals during the half-term break.

The government also said a further 102 people had died within 28 days of testing positive for Covid-19 as of Monday, while there were a further 20,890 lab-confirmed cases of coronavirus in the UK.

Elsewhere, the Oxford University and AstraZeneca PLC Covid-19 vaccine shows a "strong immune response" among elderly participants, according to experts.

Meanwhile, the Welsh government explained it will "continue to learn lessons" about how it communicates its lockdown rules following confusion over a ban on selling non-essential items.

source: PA

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.